Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the effectiveness and safety of 5% minoxidil topical foam for male pattern hair loss (androgenetic alopecia); the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Minoxidil 5% topical foam (minoxidil)

Snippet

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide | Conditions: Androgenetic Alopecia | Phase 3 | Status: COMPLETED